Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2018 Nov 28;25(5):1045–1052. doi: 10.1016/j.bbmt.2018.11.030

Table 1.

Definitions of comorbidities included in the augmented comorbidity/age index and their corresponding scores

Comorbidity Definition Score
HCT-CI
 Arrhythmia Any type of arrhythmia that has necessitated the delivery of a specific anti-arrhythmia treatment at any time point in the patient’s past medical history. 1
 Cardiac Coronary artery disease,§ congestive heart failure, myocardial infarction, or EF ≤50% 1
 Inflammatory bowel disease Crohn’s disease or ulcerative colitis requiring treatment at any time point in patient’s past medical history. 1
 Diabetes Requiring treatment with insulin or oral hypoglycemic agents continuously for 4 weeks before start of conditioning 1
 Cerebrovascular disease Transient ischemic attack or cerebrovascular accident 1
 Psychiatric disturbance Any disorder requiring continuous treatments for 4 weeks before start of conditioning 1
 Hepatic, mild Chronic hepatitis, bilirubin > ULN to 1.5 × ULN, or AST/ALT> ULN to 2.5 × ULN; at least two values of each within 2 or 4 weeks before start of conditioning. 1
 Obesity Patients with a body mass index >35 kg/m2 for patients older than 18 years or a BMI-for-age of ≥ 95th percentile for patients of ≤ 18 years of age 1
 Infection Requiring antimicrobial treatment starting from before conditioning and continued beyond day 0 1
 Rheumatologic Requiring specific treatment at any time point in the patient’s past medical history 2
 Peptic ulcer Based on prior endoscopic or radiologic diagnosis 2
 Moderate/severe renal Serum creatinine > 2 mg/dl (at least two values of each within 2 or 4 weeks before start of conditioning), on dialysis, or prior renal transplantation 2
 Moderate pulmonary Corrected DLco (via Dinakara equation) and/or FEV1 of 66%–80% or dyspnea on slight activity 2
 Prior malignancy Treated at any time point in the patient’s past history, excluding non-melanoma skin cancer 3
 Heart valve disease Of at least moderate severity, prosthetic valve, or symptomatic mitral valve prolapse as detected by echocardiogram 3
 Severe pulmonary Corrected DLco (via Dinakara equation) and/or FEV1 ≤ 65% or dyspnea at rest or requiring oxygen 3
 Moderate/severe hepatic Liver cirrhosis, bilirubin > 1.5 × ULN, or AST/ALT > 2.5 × ULN; at least two values of each within 2 or 4 weeks before start of conditioning 3
Augmented comorbidity/age index: all of the above plus
 High ferritin Values of ≥2500 as measured the closest prior to start of conditioning 1
 Mild hypoalbuminemia Values of <3.5–3.0 as measured the closest prior to start of conditioning 1
 Moderate gypoalbuminemia Values of < 3.0 as measured the closest prior to start of conditioning 2
 Thrombocytopenia Values of <100,000 as measured the closest prior to start of conditioning 1
 Age ≥40 years 1

Abbreviations: EF = ejection fraction; ULN= upper limit of normal; DLco= diffusion capacity of carbon monoxide: FEV1= forced expiratory volume in 1 second.

§

One or more vessel-coronary artery stenosis requiring medical treatment, stent, or bypass graft